Follow
Shereen Ezzat
Shereen Ezzat
Professor of Medicine, University of Toronto
Verified email at utoronto.ca
Title
Cited by
Cited by
Year
The prevalence of pituitary adenomas: a systematic review
S Ezzat, SL Asa, WT Couldwell, CE Barr, WE Dodge, ML Vance, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
16622004
Thyroid incidentalomas: prevalence by palpation and ultrasonography
S Ezzat, DA Sarti, DR Cain, GD Braunstein
Archives of internal medicine 154 (16), 1838-1840, 1994
12371994
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo, S Ezzat, SL Asa
Nature Reviews Cancer 6 (4), 292-306, 2006
11482006
Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting
NF Gonzalez-Cadavid, WE Taylor, K Yarasheski, I Sinha-Hikim, K Ma, ...
Proceedings of the National Academy of Sciences 95 (25), 14938-14943, 1998
9331998
The cytogenesis and pathogenesis of pituitary adenomas
SL Asa, S Ezzat
Endocrine reviews 19 (6), 798-827, 1998
5471998
The pathogenesis of pituitary tumours
SL Asa, S Ezzat
Nature Reviews Cancer 2 (11), 836-849, 2002
5132002
Immunohistochemical diagnosis of papillary thyroid carcinoma
CC Cheung, S Ezzat, JL Freeman, IB Rosen, SL Asa
Modern pathology 14 (4), 338-342, 2001
4932001
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update
L Katznelson, JLD Atkinson, DM Cook, SZ Ezzat, AH Hamrahian, ...
Endocrine practice 17, 1-44, 2011
4882011
Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings
E Thodou, SL Asa, G Kontogeorgos, K Kovacs, E Horvath, S Ezzat
The Journal of Clinical Endocrinology & Metabolism 80 (8), 2302-2311, 1995
4661995
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis
AM Sawka, L Thabane, L Parlea, I Ibrahim-Zada, RW Tsang, JD Brierley, ...
Thyroid 19 (5), 451-457, 2009
4132009
Diagnosis and management of hyperprolactinemia
O Serri, CL Chik, E Ur, S Ezzat
Cmaj 169 (6), 575-581, 2003
4082003
Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia
SL Sugg, S Ezzat, IB Rosen, JL Freeman, SL Asa
The Journal of Clinical Endocrinology & Metabolism 83 (11), 4116-4122, 1998
3971998
Insulin and related factors in premenopausal breast cancer risk
ME Del Giudice, IG Fantus, S Ezzat, G McKeown-Eyssen, D Page, ...
Breast cancer research and treatment 47, 111-120, 1998
3851998
Octreotide treatment of acromegaly: a randomized, multicenter study
S Ezzat, PJ Snyder, WF Young, LD Boyajy, C Newman, A Klibanski, ...
Annals of Internal Medicine 117 (9), 711-718, 1992
3721992
The pathogenesis of pituitary tumors
SL Asa, S Ezzat
Annual Review of Pathology: Mechanisms of Disease 4, 97-126, 2009
3432009
Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst
JL Shin, SL Asa, LJ Woodhouse, HS Smyth, S Ezzat
The Journal of Clinical Endocrinology & Metabolism 84 (11), 3972-3982, 1999
3431999
Acromegaly: clinical and biochemical features in 500 patients
S EZZAT, MJ FORSTER, P BERCHTOLD, DA REDELMEIER, V BOERLIN, ...
Medicine 73 (5), 233-240, 1994
3361994
Overview of the 2022 WHO classification of neuroendocrine neoplasms
G Rindi, O Mete, S Uccella, O Basturk, S La Rosa, LAA Brosens, S Ezzat, ...
Endocrine Pathology 33 (1), 115-154, 2022
3072022
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
SL Asa, O Casar-Borota, P Chanson, E Delgrange, P Earls, S Ezzat, ...
Endocrine-related cancer 24 (4), C5-C8, 2017
2902017
Mutations of the MEN1 Tumor Suppressor Gene in Pituitary Tumors
Z Zhuang, SZ Ezzat, AO Vortmeyer, R Weil, EH Oldfield, WS Park, S Pack, ...
Cancer research 57 (24), 5446-5451, 1997
2741997
The system can't perform the operation now. Try again later.
Articles 1–20